HUM-MOLGEN: recent postings

Meetings and Conferences: Others: No two clinical trials are the same, and therefore patient support can't be one-size-fits-all. Some patient populations, whether facing a rare disease, a difficult oncology diagnosis or significant tr
Improve Clinical Trial Retention with Patient Population Support
Xtalks — The Life Science Community™, Online webinar
2026-10-21

Meetings and Conferences: Microbiology / Virology: Cardiovascular outcomes trials (CVOTs) are among the most complex and resource-intensive studies in drug development, where operational execution can significantly affect timelines, capital efficiency
Why CVOTs Require a Different Approach: Optimizing Event Accrual to Reduce Trial Delays
Xtalks — The Life Science Community™, Online webinar
2026-10-23

Meetings and Conferences: Others: Finding the right participants remains one of the biggest challenges in clinical research. Precision recruitment offers a more targeted, data-informed approach, helping researchers understand who may
Accelerate Participant Identification with Precision Recruitment
Xtalks — The Life Science Community™, Online webinar
2026-10-22

Meetings and Conferences: Others: Pharmacovigilance intake processes must keep pace with the growing volume and variety of incoming data. Potential adverse events and product quality complaints can arrive through emails, lab reports,
Improve Pharmacovigilance Quality with AI-Enabled Case Intake
Xtalks — The Life Science Community™, Online webinar
2026-10-28

Meetings and Conferences: Microbiology / Virology: Early-phase clinical development is becoming increasingly complex, requiring sponsors to generate robust proof-of-concept data while navigating evolving study designs, diverse patient populations and
Accelerating Proof-of-Concept for Complex Early-Phase Studies
Xtalks — The Life Science Community™, Online webinar
2026-10-09

Meetings and Conferences: Others: The latest innovations in cell bank manufacturing can help accelerate biologic therapeutics program while reducing risk and simplifying overall strategy. As industry expectations continue to evolve, e
Reduce Cell Bank Manufacturing Risk and Accelerate Characterization
Xtalks — The Life Science Community™, Online webinar
2026-10-20

Meetings and Conferences: Others: Bispecific antibodies are among the most promising and most demanding modalities in biologics today. Their dual-targeting architecture introduces molecular complexity that monoclonal antibody platform
An Integrated Approach to De-Risking Bispecific Antibody Development
Xtalks — The Life Science Community™, Online webinar
2026-11-04

Meetings and Conferences: Microbiology / Virology: Clinical trial feasibility has long been constrained by the same fundamental problem: the data used to estimate patient availability rarely reflects the patients who will actually enroll. Site surveys
Feasibility Without Guesswork: Unlocking Genomic and Real-World Data for Faster Study Execution
Xtalks — The Life Science Community™, Online webinar
2026-11-04

Meetings and Conferences: Pharmacogenetics / Pharmacogenomics: From Robust Clone Outgrowth to GMP-Ready Cell Banks Ensuring the clinical reliability of iPSC-derived products begins with genetically stable and well-characterized starting materials. This webinar pr
Optimizing Single-Cell Cloning Workflows for iPSC Manufacturing
Xtalks — The Life Science Community™, Online webinar
2026-10-29

Meetings and Conferences: Others: Weight-loss medications work only while patients keep taking them. The real goal is staying on medication long enough to achieve meaningful, functional weight loss and sustain it. This webinar explore
Beyond Biometrics: Connecting Behavioral Profiles to Achieve the Right Kind of Weight Loss
Xtalks — The Life Science Community™, Online webinar
2026-10-29

Meetings and Conferences: Others: Plasma fractionators face increasing pressure to improve process efficiency, product consistency and manufacturing resilience while operating in regulated, high-throughput environments. This webinar w
Advancing Plasma Protein Purification with Scalable Chromatography Strategies
Xtalks — The Life Science Community™, Online webinar
2026-10-08

Meetings and Conferences: Others: As AAV-based gene therapy programs move from late-stage clinical development toward commercialization, Chemistry, Manufacturing and Controls (CMC) execution often becomes a key determinant of launch r
From Platform Knowledge to Commercial Readiness: Accelerating and De-risking your AAV Therapy’s Path to Patients
Xtalks — The Life Science Community™, Online webinar
2026-10-13

Meetings and Conferences: Microbiology / Virology: Psychedelic clinical trials present unique challenges that can make successful execution fundamentally different from small molecules. The psychedelic experience, blinding, psychotherapy assistance an
Executing Successful Psychedelic Studies from Protocol to Patient
Xtalks — The Life Science Community™, Online webinar
2026-10-22

Meetings and Conferences: Microbiology / Virology: Neurodegenerative clinical trials present unique challenges that extend beyond scientific and operational complexity. Disease progression, caregiver responsibilities, travel burden, complex assessment
Beyond the Protocol: Advancing Patient- and Caregiver-Centered Approaches in Neurodegenerative Clinical Trials
Xtalks — The Life Science Community™, Online webinar
2026-10-21

Meetings and Conferences: Others: In dermatology clinical trials, seeing change and proving clinically meaningful change are not the same thing. Disease can fluctuate between visits, severity can vary across body regions and patients
Beyond the Surface: Navigating Endpoint Complexity & Safety in Dermatology Clinical Trials
Xtalks — The Life Science Community™, Online webinar
2026-10-15

Meetings and Conferences: Neurology / Neuroscience: Alzheimer’s disease involves multiple pathological processes that emerge and evolve across the disease continuum, creating a need for biomarkers that capture different aspects of disease biology. Plas
Improve Tau Tangle Detection with Emerging Plasma eMTBR-Tau
Xtalks — The Life Science Community™, Online webinar
2026-10-02

Meetings and Conferences: Microbiology / Virology: Using patient-centric trial design and biomarker insights to support confident development decisions Generating meaningful clinical insights as early as possible is a growing priority in neurodegenera
Strategic approaches for early clinical trials in neurodegenerative diseases
Xtalks — The Life Science Community™, Online webinar
2026-10-14

Meetings and Conferences: Microbiology / Virology: Artificial intelligence (AI) is creating new opportunities across clinical development, from improving trial planning and execution to generating faster, more meaningful insights. As organizations con
The Practical Reality of AI in Clinical Development: Governing AI for Trust, Impact and Operational Readiness
Xtalks — The Life Science Community™, Online webinar
2026-10-13

Meetings and Conferences: Gene Therapy: 4th Global Cell and Gene Therapy Summit
4th Global Cell and Gene Therapy Summit (CGT Summit 2027)
United Scientific Group, Four Points by Sheraton Wakefield Boston Hotel & Conference Center
Boston, MA

Meetings and Conferences: Others: Biomarker-driven clinical trials are becoming more complex as precision medicine expands across therapeutic areas. Multi-analyte algorithms, blood-based assays, spatial biology and companion diagnosti
Advance Clinical Trial Enrichment with Operational Precision Biomarkers
Xtalks — The Life Science Community™, Online webinar
2026-09-15